GH : Insider Transactions for Guardant Health, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Guardant Health, Inc. (GH)

$0.00 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

121,380,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0 - $0

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	2,187	2,187	5,168	98,220
Total Buy Value	$38,963	$38,963	$136,461	$2,585,297
Total People Bought	1	1	1	2
Total Buy Transactions	1	1	2	4
Total Shares Sold	100	6,000	10,991	31,616
Total Sell Value	$1,905	$157,493	$334,111	$1,291,105
Total People Sold	1	2	2	3
Total Sell Transactions	1	3	6	11
End Date	2024-02-22	2023-11-21	2023-05-23	2022-05-23

Adjust Filter Settings

Records found: 671

Page 13 of 27

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-03

4

AS

$156.94

$1,819,222

I/I

(11,462)

575,571

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-03

4

AS

$156.92

$12,207,772

D/D

(76,915)

2,428,365

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-02

4/A

AS

$158.91

$9,392,059

D/D

(59,040)

2,622,946

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-02

4

AS

$155.87

$3,083,832

I/I

(19,498)

587,033

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-02

4

AS

$155.88

$20,702,229

D/D

(130,893)

2,622,883

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-01

4

AS

$152.16

$2,203,337

I/I

(14,269)

606,531

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-02-01

4

AS

$152.17

$14,784,239

D/D

(95,744)

2,753,776

-

Director

– • –

2021-01-25

4

AS

$162.00

$87,156

D/D

(538)

4,643

-

Director

– • –

2021-01-25

4

OE

$4.18

$2,249

D/D

538

5,181

-

Chief Executive Officer

• • –

2021-01-25

4

AS

$153.29

$9,248,642

D/D

(58,811)

2,627,763

-

Chief Executive Officer

• • –

2021-01-22

4

AS

$158.79

$16,322,404

D/D

(102,075)

2,686,574

-

Chief Executive Officer

• • –

2021-01-21

4

AS

$160.29

$28,061,525

D/D

(173,206)

2,788,649

-

Chief Executive Officer

• • –

2021-01-20

4

AS

$160.96

$27,418,473

D/D

(167,663)

2,961,855

-

Chief Executive Officer

• • –

2021-01-20

4

AS

$160.95

$7,281,807

I/I

(44,528)

365,775

-

Chief Executive Officer

• • –

2021-01-19

4

AS

$158.22

$16,606,912

I/I

(103,717)

410,303

-

Chief Executive Officer

• • –

2021-01-15

4

AS

$156.09

$23,758,873

I/I

(150,000)

514,020

-

Meresman Stanley J

Director

– • –

2021-01-11

4

AS

$142.00

$700,628

D/D

(4,934)

4,059

-

Meresman Stanley J

Director

– • –

2021-01-11

4

OE

$5.94

$29,308

D/D

4,934

8,993

-

Chief Executive Officer

• • –

2021-01-06

4

D

$129.54

$36,158,112

D/D

(279,127)

3,129,518

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-01-06

4

D

$129.54

$36,158,112

D/D

(279,127)

2,849,520

-

Director

– • –

2021-01-04

4

AS

$129.23

$347,629

D/D

(2,690)

4,643

-

Director

– • –

2021-01-04

4

OE

$4.18

$11,244

D/D

2,690

7,333

-

Chief Executive Officer

• • –

2021-01-01

4

OE

$0.00

$0

D/D

565,192

3,408,645

-

Talasaz Amirali

Chairman, President and COO

• • –

2021-01-01

4

OE

$0.00

$0

D/D

565,192

3,128,647

-

Director

– • –

2020-12-28

4

AS

$135.00

$72,630

D/D

(538)

4,643

-

671 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 13 of 27

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.